CompoAtlas

Genestra Brands Femagen PMS Tablets

Testo originale in francese.

Genestra Brands Femagen PMS Tablets, NPN 80082517: prodotto di salute naturale autorizzato in Canada. Ingredienti medicinali: Magnésium, Bêta-carotène, Bos Taurus, Folate.

Se questo prodotto fosse venduto in Francia

Si calcola una quantità giornaliera solo per una posologia orale esplicita per adulti, espressa al giorno e in un’unità solida corrispondente alla forma del prodotto. Unità ambigue, liquidi, polveri e dosi pediatriche non vengono estrapolati. Una quantità non calcolata non viene confrontata con i limiti di dose. Questa analisi non costituisce un’autorizzazione alla vendita in Francia né una valutazione di sicurezza o efficacia.

Composizione

Ingrediente medicinale e fontePer unità posologica, secondo la fonteMassimo giornaliero, adulto
Magnésium

Fonte : Citrate de magnésium

100 milligramme200.000 µg
Bêta-carotène

Fonte : bêta-carotène

1.200 microgrammesNon calcolata
Bos Taurus

Fonte : Ovaire

50 milligrammeNon calcolata
Bos Taurus

Fonte : Glande surrénale

25 milligrammeNon calcolata
Folate

Fonte : L-5 Méthyltétrahydrofolate, sel de calcium

150 microgrammesNon calcolata
Fer

Fonte : Diglycinate de fer (II)

10 milligramme20.000 µg
Niacine

Fonte : Acide nicotinique

15 milligrammeNon calcolata
Acide pantothénique

Fonte : D-Pantothénate de calcium

10 milligramme20.000 µg
Riboflavine

Fonte : Riboflavine

10 milligramme20.000 µg
Sus scrofa

Fonte : Cerveau

25 milligrammeNon calcolata
Taraxacum officinale

Fonte : Feuille

10 milligrammeNon calcolata
Thiamine10 milligramme20.000 µg
Vitamine B12

Fonte : Méthylcobalamine

25 microgrammesNon calcolata
Vitamine B6

Fonte : Pyridoxal 5'-phosphate

50 milligramme100.000 µg
Vitamine E

Fonte : Succinate d'acide de d-alpha tocophéryle

34 mg ATNon calcolata
Zinc

Fonte : Citrate de zinc

5 milligramme10.000 µg
Calcium

Fonte : Citrate de calcium

50 milligramme100.000 µg
Vitex agnus-castus

Fonte : Fruit

Estratto : Matériel brut sec

Rapporto di estrazione : 7-10:1

Equivalente di pianta secca : 350-500 mg

50 milligrammeNon calcolata
Choline

Fonte : Bitartrate de choline

15 milligrammeNon calcolata

Ingredienti non medicinali

Hypromellose, Glycérine, Silice, Cellulose, Croscarmellose de sodium, Hydroxypropylcellulose, Stéarate de magnésium

Dosi raccomandate in Canada

PopolazioneEtàQuantità per assunzioneFrequenza
Adultesminimum : 19 ans1 Comprimé2 Tous les jours

Usi autorizzati in Canada

Provitamin A for the maintenance of good health. Provitamin A to help maintain eyesight, skin, membranes and immune function. Provitamin A to help in the development and maintenance of night vision. Provitamin A to help in the development and maintenance of bones and teeth. Helps to form red blood cells. Helps to support normal early fetal development. Helps to support normal early development of the fetal brain and spinal cord. Helps normal growth and development. Helps in energy metabolism and tissue formation. Helps to maintain the body's ability to metabolize nutrients. Helps to maintain healthy mucous membranes. Helps to maintain normal red blood cells. Helps to maintain normal metabolism of iron. Helps in energy production. Helps in the normal function of the immune system. Helps to form red blood cells and helps in their proper function. Helps to reduce tiredness and fatigue caused by iron deficiency anemia. Helps pregnant women meet (the) (Health Canada's) recommended intake for iron, when taken in conjunction with a healthy diet. Helps to prevent iron deficiency. Helps to prevent iron deficiency anaemia. Helps to prevent iron deficiency anemia and associated tiredness and fatigue. Helps in the development and maintenance of bones and teeth. Helps to maintain proper muscle function. Helps to maintain proper muscle function, including the heart muscle. Source of/An electrolyte for the maintenance of good health. Helps in energy metabolism, tissue formation and bone development. Helps to maintain normal electrolyte balance. Used in Herbal Medicine to help relieve premenstrual symptoms. Used in Herbal Medicine as a hormone normaliser to help stabilise menstrual cycle irregularities. Used in Herbal Medicine to help relieve symptoms associated with menopause, such as hot flushes.

Testo originale in francese.

Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.

Avvertenze in Canada

Known Adverse Reactions : People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient. Do not use if you are pregnant, breastfeeding or attemptin to conceive unless you have consulted with a health care practitioner/health are providers/health care professional/doctor/physician.

Testo originale in inglese.

Cautions and Warnings : Keep out of reach of children. There is enough iron in this package to seriously harm a child. Consult a health care practitioner prior to use, if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy, if you have liver or gall bladder diseases, and/or intestinal obstruction. Consult a health care practitioner if symptoms persist or worsen.

Testo originale in inglese.

Scheda del prodotto

Titolare
Seroyal International
NPN o DIN-HM
80082517
Stato
Licenza attiva
Data della licenza
19 gennaio 2018
Data di revisione
15 maggio 2024
Forma
Comprimé
Via di somministrazione
Orale
Tipo di domanda
Non traditionnelle

Fonte

Scheda ufficiale Health Canada, licenza 80082517

Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Testo originale in inglese.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Testo originale in francese.

La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.

Avvertenze ufficiali (Health Canada)

Health Canada pubblica avvertenze su questi ingredienti:

  • Vitex agnus-castus
    Leggere l'avvertenza, quando si applica e gli studi citati

    Testo originale ufficiale in inglese.

    CHASTE TREE - VITEX AGNUS-CASTUS

    Via di somministrazione: Oral (WHO 2009; Bradley 2006; Mills and Bone 2000)

    Precauzioni e avvertenze

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy (Brinker 2010; WHO 2009; Bradley 2006).

    Fonti citate da Health Canada (4)
    • Bradley PR, editor. 2006. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • WHO 2009: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 4. Geneva (CH): World Health Organization.
    • OMS 2009: Organisation mondiale de la santé. WHO Monographs on Selected Medicinal Plants, Volume 4. Genève (CH): Organisation mondiale de la santé.

    Controindicazioni

    Do not use if you are pregnant, breastfeeding or attempting to conceive unless you have consulted with a health care practitioner/health care provider/health care professional/doctor/physician (EMA 2018; Najib et al. 2022; Brinker 2010; WHO 2009; Dugoua et al. 2008; ESCOP 2003; Blumenthal 2000; Mills and Bone 2000).

    Fonti citate da Health Canada (9)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. 2000. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Dugoua JJ, Seely D, Pern D, Koren G, Mills E. Safety and efficacy of chastetree (Vitex Agnus-Castus) during pregnancy and lactation. Can J. Clin Pharmacol 2008;15(1);e74-e79.
    • EMA 2018. European Medicines Agency. European Union herbal monograph on Vitex agnus-castus L., fructus. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 27 March 2018. [Accessed 2024 February 29] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-vitex-agnus-castus-l-fructus-revision-1_en.pdf
    • ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy in collaboration with Thieme.
    • Mills S, Bone K. 2000. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone.
    • Najib FS, Poordast T, Mahmudi MS, Shiravani Z, Namazi N, Omrani GR. Does Vitex Agnus-Castus L. Have Deleterious Effect on Fertility and Pregnancy Outcome? An Experimental Study on Rats for Prediction of Its Safety. J. Pharmacopuncture 2022;25(2):106-113. PubMed
    • WHO 2009: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 4. Geneva (CH): World Health Organization.
    • OMS 2009: Organisation mondiale de la santé. WHO Monographs on Selected Medicinal Plants, Volume 4. Genève (CH): Organisation mondiale de la santé.

    Monografia di Health Canada del 28 marzo 2024

Riguardano l'ingrediente, non questo prodotto né la sua dose. Non sostituiscono il parere medico.

Elenco nella revisione ufficiale del (registro: Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze).

Fotografare la confezione

Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.

Elenco rilevato nel 2024. Fotografi la confezione per verificare eventuali modifiche.

Invio per analizzare, Maiusc+Invio per una nuova riga